Combination of Palbociclib and Erlotinib Exhibits Synergistic Antitumor Effect in Colorectal Cancer Patient-Derived Xenograft (PDX) ModelsXiaohui Zhou, Fan Lin, Zhen Chen et al.|Research Square|2021Cited by 2
Genome-wide CRISPR/Cas9 screen identified MCL1 as a senolytic target for clearing palbociclib-induced senescent and PD-L1-positive cells in colorectal cancerHao Wang, Fan Lin, Tianqi Shen et al.|Cancer Letters|2026Cited by 1